Cancer Immunotherapy Reduces Risk Of Relapse After Surgery, Stud...

Courtesy ScienceDaily  Thu, 04/24/2008 - 23:00

New, long-term results from a clinical trial show that MAGE-A3 ASCI, an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery -- to the same extent as chemotherapy but without the side-effects of chemotherapy.


 

More related items

Gene Panel Predicts Lung Cancer Survival, Study Finds
Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The...

Why Only Some Former Smokers Develop Lung Cancer
Canadian researchers are trying to answer why some smokers develop lung cancer while others remain disease free, despite similar lifestyle changes.

Broccoli May Lower Lung Cancer Risk In Smokers
The cancer preventive properties of broccoli and other cruciferous vegetables appear to work specifically in smokers, according to new research.

Soapmaker's Companion: A Comprehensive Guide with...
Basic soapmaking instruction and specialty techniques like marbling, layering, and making transparent and liquid soaps.

The Black Hole War: My Battle with Stephen Hawking to...
What happens when something is sucked into a black hole? Does it disappear? Three decades ago, a young physicist named Stephen Hawking claimed it did-and in doing so put at risk everything we...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com